Coya Therapeutics, Inc.
COYA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001835022
No open-market purchases or sales by Coya Therapeutics, Inc. insiders were filed in the last 90 days; 54 institutions reported holding it in 13F filings for Q2 2026, worth $45.5M in total; Greenlight Capital is the only superinvestor holding it.
13F holders, Q4 2023
Institutional positions in Coya Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +6 vs. Q3 2023
- Shares held
- 2.82M
- +1.41M (+99.2%) vs. Q3 2023
- Total value
- $20.6M
- +$15.2M (+278.9%) vs. Q3 2023
- New holders
- 6
- 9 more added
- Sold out
- 0
- 3 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting COYA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 54 | $45.5M |
| Q1 2026 | 57 | $32.0M |
| Q4 2025 | 58 | $46.0M |
| Q3 2025 | 36 | $27.1M |
| Q2 2025 | 33 | $25.8M |
| Q1 2025 | 26 | $30.2M |
| Q4 2024 | 26 | $25.5M |
| Q3 2024 | 19 | $21.4M |
| Q2 2024 | 19 | $19.8M |
| Q1 2024 | 19 | $33.1M |
| Q4 2023 | 21 | $20.6M |
| Q3 2023 | 15 | $5.45M |
| Q2 2023 | 14 | $5.50M |
| Q1 2023 | 7 | $4.37M |
| Q4 2022 | 4 | $5.16M |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Coya Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 10 | $74 | 0.00% | +10 | New |
| Wells Fargo & Company | 65 | $482 | 0.00% | +4+6.6% | Added |
| JPMorgan Chase & Co | 65 | $482 | 0.00% | +60+1,200.0% | Added |
| Tucker Asset Management LLC | 200 | $1.48K | 0.00% | +200 | New |
| Royal Bank of Canada | 209 | $2.00K | 0.00% | +108+106.9% | Added |
| Morgan Stanley | 500 | $3.71K | 0.00% | −1−0.2% | Reduced |
| Tradition Wealth Management, LLC | 849 | $6.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,479 | $18.4K | 0.00% | +2,479 | New |
| Tower Research Capital LLC (TRC) | 3,344 | $24.8K | 0.00% | +1,243+59.2% | Added |
| Northern Trust Corp | 14,873 | $110.2K | 0.00% | +14,873 | New |
| Mirador Capital Partners LP | 16,127 | $119.5K | 0.03% | +214+1.3% | Added |
| Citadel Advisors LLC | 16,592 | $122.9K | 0.00% | +16,592 | New |
| Potomac Capital Management, Inc. | 21,101 | $156.4K | 0.22% | +21,101 | New |
| BlackRock Inc. | 21,775 | $161.4K | 0.00% | −244−1.1% | Reduced |
| Prelude Capital Management, LLC | 35,770 | $265.1K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 92,465 | $685.3K | 0.00% | +5,400+6.2% | Added |
| Worth Venture Partners, LLC | 92,667 | $686.7K | 0.37% | −41,339−30.8% | Reduced |
| Vanguard Group Inc | 97,152 | $719.9K | 0.00% | +82,948+584.0% | Added |
| CM Management, LLC | 100,000 | $741.0K | 0.60% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 1,031,977 | $7.38M | 2.92% | +496,183+92.6% | Added |
| Greenlight Capital Inc | 1,274,026 | $9.44M | 0.46% | +805,959+172.2% | Added |